Oct 20, 2020 |
Padmaja Chinta has been appointed as the Chief Diversity Officer for the Federal Bar Association’s Southern District of New York chapter for 2021. This is a new role and initiative created by the FBA.
Read MoreJun 29, 2020 |
Partner Padmaja Chinta of Chinta & Fratangelo LLP has been selected as a Fellow of the Litigation Counsel of America. She is a litigator in the firm’s intellectual property practice and a graduate of the University of Pennsylvania Law School....
Read MoreNov 13, 2019 |
An issue for many tech entrepreneurs is whether they should spend the resources (money and time) on getting a patent. Let me address the issues here why you should or should not get a patent. Before we even get to...
Read MoreOct 16, 2019 |
My clients have learned from their mistakes and currently understand the importance of having the advice of a qualified attorney prior to signing with a publisher. Because these mistakes or pitfalls often come with a hefty price tag down the...
Read MoreMay 04, 2019 |
ATTENTION DIGITAL AND BOARD GAME DEVELOPERS! One area of practice that I particularly enjoy is helping game developers secure their intellectual property rights. The gaming industry is interesting from a legal perspective particularly because it involves the three main areas...
Read MoreApr 09, 2019 |
OFFENSIVE AND DEFENSIVE PATENTING AS A STRATEGIC OPTION TO PROTECT YOUR INVENTIONS A patent gives the patent owner the ability to exclude someone else from practicing the claimed invention, which can lead to market exclusivity if a product is within...
Read MoreApr 08, 2019 |
THE HATCH-WAXMAN ACT (SIMPLY EXPLAINED) The Hatch-Waxman Act (formally known as the Drug Price Competition and Patent Term Restoration Act) is a law passed in 1984 that created the generic drug industry as we know it today in the United...
Read MoreApr 03, 2019 |
WHAT IS A WRITTEN DESCRIPTION IN A PATENT? A critical aspect in patent drafting is the “written description requirement” (35 USC §112(a)). This is a standard feature of all patent systems, which requires that claims be “supported” by the specification....
Read MoreApr 02, 2019 |
DEVELOPMENTS IN OBVIOUSNESS LAW AND HOW IT COULD AFFECT YOUR INVENTION In the recent Acorda Therapeutics, Inc. v. Roxane Laboratories, Inc., No. 2017-2078 (Fed. Cir. Sept.10, 2018) decision, the Federal Circuit (the US appeals court for all patent cases) made...
Read MoreMar 30, 2019 |
THE PROBLEM-SOLUTION APPROACH Patent prosecution is one of my sharpest skills, and I just got word of an important patent allowance for one of my biotech cases. The beauty of receiving this notice was compounded by the strategy and approach...
Read More